Weirong Fang

Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Correction: Berberine attenuates ischemia reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.

Correction: Berberine attenuates ischemia reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.

Journal: Acta pharmacologica Sinica

Published: March 10, 2026

Corrigendum to "XQ-1H alleviates cerebral ischemia in mice through inhibition of apoptosis and promotion of neurogenesis in a Wnt/β-catenin signaling dependent way" [Life Sci. 235 (2019) 116844].

Corrigendum to "XQ-1H alleviates cerebral ischemia in mice through inhibition of apoptosis and promotion of neurogenesis in a Wnt/β-catenin signaling dependent way" [Life Sci. 235 (2019) 116844].

Journal: Life sciences

Published: February 14, 2026

Corrigendum to "Total glucosides of paeony (TGP) alleviates constipation and intestinal inflammation in mice induced by Sjögren's syndrome" [J. Ethnopharmacol. (2020) 260 113056].

Corrigendum to "Total glucosides of paeony (TGP) alleviates constipation and intestinal inflammation in mice induced by Sjögren's syndrome" [J. Ethnopharmacol. (2020) 260 113056].

Journal: Journal of ethnopharmacology

Published: May 23, 2025

Corrigendum to "The molecular insight into the antihyperuricemic and renoprotective effect of Shuang Qi gout capsule in mice" [J. Ethnopharmacol. 163 (2015) 278-289].

Corrigendum to "The molecular insight into the antihyperuricemic and renoprotective effect of Shuang Qi gout capsule in mice" [J. Ethnopharmacol. 163 (2015) 278-289].

Journal: Journal of ethnopharmacology

Published: April 19, 2025

Total glucosides of paeony alleviates Sjogren's syndrome by inhibiting Th1 and Th17 responses.

Total glucosides of paeony alleviates Sjogren's syndrome by inhibiting Th1 and Th17 responses.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 07, 2024

Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together.

Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together.

Journal: Translational psychiatry

Published: July 31, 2023

Mesencephalic astrocyte-derived neurotrophic factor (MANF) alleviates cerebral ischemia/reperfusion injury in mice by regulating microglia polarization via A20/NF-κB pathway.

Mesencephalic astrocyte-derived neurotrophic factor (MANF) alleviates cerebral ischemia/reperfusion injury in mice by regulating microglia polarization via A20/NF-κB pathway.

Journal: International immunopharmacology

Published: March 31, 2023

Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts.

Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts.

Journal: Archives of toxicology

Published: October 08, 2022

Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence.

Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence.

Journal: European journal of clinical pharmacology

Published: August 24, 2022

The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review.

The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review.

Journal: Frontiers in psychiatry

Published: September 24, 2021

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.

Journal: Frontiers in pharmacology

Published: September 07, 2021

Improvement of tube formation model of cell: Application for acute hypoxia in in vitro study of angiogenesis.

Improvement of tube formation model of cell: Application for acute hypoxia in in vitro study of angiogenesis.

Journal: Microvascular research

Published: June 23, 2021

Showing 1-12 of 53

Last Updated: 09/26/2026